Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.

STAINES-UPON-THAMES, United Kingdom, Feb. 13, 2018 -- (Healthcare Sales & Marketing Network) -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has closed the acquisition of Sucampo Pharmaceuticals, Inc.... Biopharmaceuticals, Mergers & Acquisitions Mallinckrodt, Sucampo Pharmaceuticals
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news